Lomustine and melphalan cannot be replaced by cyclophosphamide and etoposide without reducing efficacy in MOPPEBVCAD chemotherapy for advanced Hodgkin's disease

P. G. Gobbi, C. Broglia, R. Berte, M. P. Petrilli, S. Molica, F. Angrilli, E. Iannitto, M. L. Ghirardelli, N. Di Renzo, L. Cavanna, E. Ascari

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Lomustine and melphalan cannot be replaced by cyclophosphamide and etoposide without reducing efficacy in MOPPEBVCAD chemotherapy for advanced Hodgkin's disease'. Together they form a unique fingerprint.

Medicine & Life Sciences